Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)
Protocol ID
AREN1921
Disease (Sub Disease)
Wilms
Diagnosis Stage
New Diagnosis
Relapse
Location
NSW, QLD, VIC, WA, NZ
Sponsor
Children's Oncology Group
Collaborators
National Cancer Institute (NCI)
Trial Status
Open
Sites
Perth Children's Hospital
Queensland Children's Hospital
Starship Hospital
The Royal Children's Hospital
The Children's Hospital at Westmead
Christchurch Hospital
Study Type
Treatment
Phase
Phase 2
Age Eligibility
up to 30 Years
International registry ID's
NCT04322318
Back to Registry
Study Title Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)
Protocol ID AREN1921
Disease (Sub Disease) Wilms
Diagnosis Stage New Diagnosis
Relapse
Location NSW / QLD / VIC / WA / NZ
Sponsor Children's Oncology Group
Collaborators National Cancer Institute (NCI)
Links https://clinicaltrials.gov/ct2/show/NCT04322318
Trial Status Open
Trial Open Date 18/09/2020
Sites Perth Children's Hospital/ Queensland Children's Hospital/ Starship Hospital / The Royal Children's Hospital / The Children's Hospital at Westmead / Christchurch Hospital
Study Type Treatment
Phase Phase 2
Age Eligibility up to 30 Years
International registry ID's NCT04322318